Australia’s $4B oncology drugs market is growing rapidly but faces delays in patient access. With automated workflows, virtual consultations, and integrated data, Zelthy improved adherence by 45%, accelerated enrollment by 60%, and reduced operational costs by 30%, ensuring faster, more effective patient care.